Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
TriSalus Life Sciences, Inc. - Common Stock
(NQ:
TLSI
)
5.770
+0.240 (+4.34%)
Streaming Delayed Price
Updated: 11:37 AM EST, Jan 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
43,261
Open
5.580
Bid (Size)
5.770 (100)
Ask (Size)
5.850 (100)
Prev. Close
5.530
Today's Range
5.560 - 5.872
52wk Range
3.420 - 7.950
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance
January 12, 2026
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Symptomatic Thyroid Disease on December 15, 2025
December 04, 2025
From
TriSalus Life Sciences
Via
Business Wire
Performance
YTD
-5.4%
-5.4%
1 Month
-22.7%
-22.7%
3 Month
+12.7%
+12.7%
6 Month
+22.8%
+22.8%
1 Year
+18.7%
+18.7%
More News
Read More
TriSalus Life Sciences Launches TriNav® XP Infusion System to Expand Options for Pressure-Enabled Drug Delivery™
November 18, 2025
From
TriSalus Life Sciences
Via
Business Wire
Earnings Scheduled For November 13, 2025
↗
November 13, 2025
Via
Benzinga
TriSalus Life Sciences Inc (NASDAQ:TLSI) Reports Q3 2025 Results with Strong Revenue Growth but Significant EPS Miss
↗
November 13, 2025
Via
Chartmill
TriSalus (TLSI) Q3 2025 Earnings Call Transcript
↗
November 13, 2025
Via
The Motley Fool
Topics
Earnings
TriSalus Life Sciences Reports Third Quarter 2025 Results and Reaffirms 2025 Revenue Guidance
November 13, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Participate in Upcoming Investor Conferences
November 11, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Host Virtual KOL Event to Discuss the TriNav Infusion System for the Treatment of Uterine Fibroids on November 12, 2025
November 10, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Host Third Quarter 2025 Financial Results Conference Call
October 30, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Participate in Upcoming September Investor Conferences
August 28, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Inc (NASDAQ:TLSI) Reports Strong Q2 2025 Revenue Growth and Narrowed Losses
↗
August 12, 2025
Via
Chartmill
TriSalus Life Sciences Reports Second Quarter 2025 Results and Reiterates 2025 Guidance
August 12, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Publication of Safety and Efficacy Results for a Novel Pressure-Enabled Thyroid Embolization Technique
August 11, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences to Participate in the Canaccord Genuity 45th Annual Growth Conference
July 30, 2025
From
TriSalus Life Sciences
Via
Business Wire
Earnings Scheduled For August 12, 2025
↗
August 12, 2025
Via
Benzinga
TriSalus Life Sciences to Host Second Quarter 2025 Financial Results Conference Call
July 29, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock
July 24, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Commencement of Exchange Offer and Consent Solicitation Relating to Series A Convertible Preferred Stock to Streamline Capital Structure
June 23, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces the Launch of the TriNav FLX Infusion System
June 04, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience
May 30, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Reports First Quarter 2025 Results and Provides Updated 2025 Guidance
May 15, 2025
From
TriSalus Life Sciences
Via
Business Wire
Earnings Scheduled For May 15, 2025
↗
May 15, 2025
Via
Benzinga
TriSalus Life Sciences to Host First Quarter 2025 Financial Results Conference Call
May 12, 2025
From
TriSalus Life Sciences
Via
Business Wire
TriSalus Life Sciences Announces $22.0 Million Private Placement Preliminary Q1 2025 Unaudited Financial Results
April 30, 2025
From
TriSalus Life Sciences
Via
Business Wire
Frequently Asked Questions
Is TriSalus Life Sciences, Inc. - Common Stock publicly traded?
Yes, TriSalus Life Sciences, Inc. - Common Stock is publicly traded.
What exchange does TriSalus Life Sciences, Inc. - Common Stock trade on?
TriSalus Life Sciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TriSalus Life Sciences, Inc. - Common Stock?
The ticker symbol for TriSalus Life Sciences, Inc. - Common Stock is TLSI on the Nasdaq Stock Market
What is the current price of TriSalus Life Sciences, Inc. - Common Stock?
The current price of TriSalus Life Sciences, Inc. - Common Stock is 5.770
When was TriSalus Life Sciences, Inc. - Common Stock last traded?
The last trade of TriSalus Life Sciences, Inc. - Common Stock was at 01/22/26 11:37 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
